Physician

John Mclean Trotter, MD

According to 2025 Medicare claims, John Trotter, MD (NPI: 1558405902) practices interventional cardiology in the Daphne-Fairhope-Foley, AL market, with the plurality of this provider's patient population coming from Baldwin, AL. This provider's primary affiliated billing organization is CARDIOLOGY ASSOCIATES OF MOBILE INC (NPI: 1689623076; TIN: 630889615) and primary practice location at 36532-2038.

Trotter's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,706 traditional Medicare patients, billed 8,044 HCPCS/CPT codes, and received $499,190 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 7,565 prescription claims across 1,244 beneficiaries totaling $1,095,094 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 22 claims. Open Payments data shows 49 records totaling $6,271. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $323,212 to $1,095,094. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $18,989 and ending at $29,970.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,536	14,318	$537,895
2016	2,599	13,604	$500,138
2017	2,264	13,602	$416,219
2018	2,202	9,307	$434,398
2019	2,239	8,060	$494,276
2020	2,004	7,264	$548,924
2021	1,955	7,461	$703,626
2022	1,941	7,254	$652,873
2023	1,670	5,378	$500,291
2024	1,706	8,044	$499,190

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	810	6,328	$323,212
2016	920	6,574	$378,496
2017	949	6,254	$397,941
2018	921	5,584	$403,552
2019	956	5,402	$424,872
2020	967	5,847	$543,923
2021	1,108	6,193	$626,802
2022	1,152	6,796	$866,600
2023	1,173	6,988	$964,267
2024	1,244	7,565	$1,095,094

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$333
2016	N/R	N/R	N/R
2017	N/R	27	$1,040
2018	N/R	16	$1,211
2019	N/R	15	$804
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	12	$912
2023	N/R	22	$29,970
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	470	512	$75
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	468	473	$70
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	321	466	$57
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	204	211	$9
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	350	353	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	548	29,069	$552,919
Repatha Sureclick	Evolocumab	143	5,858	$112,098
Entresto	Sacubitril/Valsartan	83	4,968	$107,986
Xarelto	Rivaroxaban	102	6,030	$106,471
Farxiga	Dapagliflozin Propanediol	36	1,542	$29,026

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$93	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	45	$6,178	BIOTRONIK INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John Mclean Trotter, MD?

Tedicare shows public-source Medicare data for John Mclean Trotter, MD (NPI 1558405902), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Mclean Trotter, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Mclean Trotter, MD?

John Mclean Trotter, MD is linked to CARDIOLOGY ASSOCIATES OF MOBILE INC (billing NPI 1689623076) in the available physician profile data.

Does John Mclean Trotter, MD have Open Payments data?

John Mclean Trotter, MD has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.